A citation-based method for searching scientific literature

Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow, Filip Krag Knop, Sten Madsbad, Henrik Ullits Andersen. Lancet Diabetes Endocrinol 2016
Times Cited: 71







List of co-cited articles
595 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.
Richard S Legro, William C Dodson, Penny M Kris-Etherton, Allen R Kunselman, Christy M Stetter, Nancy I Williams, Carol L Gnatuk, Stephanie J Estes, Jennifer Fleming, Kelly C Allison,[...]. J Clin Endocrinol Metab 2015
86
1


Obesity.
Pedro González-Muniesa, Miguel-Angel Mártinez-González, Frank B Hu, Jean-Pierre Després, Yuji Matsuzawa, Ruth J F Loos, Luis A Moreno, George A Bray, J Alfredo Martinez. Nat Rev Dis Primers 2017
320
1

Obesity and Cancer: Insights for Clinicians.
Pamela J Goodwin, Rowan T Chlebowski. J Clin Oncol 2016
18
5

MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency.
Karine Clément, Heike Biebermann, I Sadaf Farooqi, Lex Van der Ploeg, Barbara Wolters, Christine Poitou, Lia Puder, Fred Fiedorek, Keith Gottesdiener, Gunnar Kleinau,[...]. Nat Med 2018
99
1


One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients.
C K Svensson, J R Larsen, L Vedtofte, M S L Jakobsen, H R Jespersen, M I Jakobsen, K Koyuncu, O Schjerning, J Nielsen, C T Ekstrøm,[...]. Acta Psychiatr Scand 2019
12
8

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
Francis S Willard, Jonathan D Douros, Maria Bn Gabe, Aaron D Showalter, David B Wainscott, Todd M Suter, Megan E Capozzi, Wijnand Jc van der Velden, Cynthia Stutsman, Guemalli R Cardona,[...]. JCI Insight 2020
32
3

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.
Julie R Larsen, Louise Vedtofte, Mathilde S L Jakobsen, Hans R Jespersen, Michelle I Jakobsen, Camilla K Svensson, Kamuran Koyuncu, Ole Schjerning, Peter S Oturai, Andreas Kjaer,[...]. JAMA Psychiatry 2017
58
1

Persistent metabolic adaptation 6 years after "The Biggest Loser" competition.
Erin Fothergill, Juen Guo, Lilian Howard, Jennifer C Kerns, Nicolas D Knuth, Robert Brychta, Kong Y Chen, Monica C Skarulis, Mary Walter, Peter J Walter,[...]. Obesity (Silver Spring) 2016
261
1


Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.
John M Miles, Lawrence Leiter, Priscilla Hollander, Thomas Wadden, James W Anderson, Michael Doyle, John Foreyt, Louis Aronne, Samuel Klein. Diabetes Care 2002
170
1

Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
John W Apolzan, Elizabeth M Venditti, Sharon L Edelstein, William C Knowler, Dana Dabelea, Edward J Boyko, Xavier Pi-Sunyer, Rita R Kalyani, Paul W Franks, Preethi Srikanthan,[...]. Ann Intern Med 2019
30
3

An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.
Estelle Lach-Trifilieff, Giulia C Minetti, KellyAnn Sheppard, Chikwendu Ibebunjo, Jerome N Feige, Steffen Hartmann, Sophie Brachat, Helene Rivet, Claudia Koelbing, Frederic Morvan,[...]. Mol Cell Biol 2014
165
1

The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes.
Yan-Ling He, William Haynes, Charles D Meyers, Ahmed Amer, Yiming Zhang, Ping Mahling, Anisha E Mendonza, Shenglin Ma, William Chutkow, Eric Bachman. Diabetes Obes Metab 2019
28
3


Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
J O Hill, J Hauptman, J W Anderson, K Fujioka, P M O'Neil, D K Smith, J H Zavoral, L J Aronne. Am J Clin Nutr 1999
190
1

Dose-dependent reduction in body weight with LIK066 (licogliflozin) treatment in Japanese patients with obesity.
Koutaro Yokote, Misako Sano, Isao Tsumiyama, Deborah Keefe. Diabetes Obes Metab 2020
5
20

Obesity is associated with hypothalamic injury in rodents and humans.
Joshua P Thaler, Chun-Xia Yi, Ellen A Schur, Stephan J Guyenet, Bang H Hwang, Marcelo O Dietrich, Xiaolin Zhao, David A Sarruf, Vitaly Izgur, Kenneth R Maravilla,[...]. J Clin Invest 2012
970
1

Long-term persistence of hormonal adaptations to weight loss.
Priya Sumithran, Luke A Prendergast, Elizabeth Delbridge, Katrina Purcell, Arthur Shulkes, Adamandia Kriketos, Joseph Proietto. N Engl J Med 2011
658
1

Neurochemical mechanism of action of anorectic drugs.
R Samanin, S Garattini. Pharmacol Toxicol 1993
90
1

Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity.
Harold E Bays, Plamen Kozlovski, Qing Shao, Pieter Proot, Deborah Keefe. Obesity (Silver Spring) 2020
6
16

Obesity Pathogenesis: An Endocrine Society Scientific Statement.
Michael W Schwartz, Randy J Seeley, Lori M Zeltser, Adam Drewnowski, Eric Ravussin, Leanne M Redman, Rudolph L Leibel. Endocr Rev 2017
166
1


Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study.
Tariq Chukir, Lindsay Mandel, Beverly G Tchang, Nada A Al-Mulla, Leon I Igel, Rekha B Kumar, Jonathan Waitman, Louis J Aronne, Alpana P Shukla. Obes Res Clin Pract 2021
2
50

Pharmacotherapy in Conjunction with a Diet and Exercise Program for the Treatment of Weight Recidivism or Weight Loss Plateau Post-bariatric Surgery: a Retrospective Review.
Jennifer Schwartz, Umer I Chaudhry, Andrew Suzo, Nicholas Durkin, Allison M Wehr, Kathy S Foreman, Kristen Tychonievich, Dean J Mikami, Bradley J Needleman, Sabrena F Noria. Obes Surg 2016
36
2

Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry.
Viral N Shah, Mengdi Wu, Sarit Polsky, Janet K Snell-Bergeon, Jennifer L Sherr, Eda Cengiz, Linda A DiMeglio, Rodica Pop-Busui, Kara Mizokami-Stout, Nicole C Foster,[...]. J Diabetes Complications 2018
14
7

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.
Francesco Rubino, David M Nathan, Robert H Eckel, Philip R Schauer, K George M M Alberti, Paul Z Zimmet, Stefano Del Prato, Linong Ji, Shaukat M Sadikot, William H Herman,[...]. Diabetes Care 2016
388
1

Obesity Pharmacotherapy in Patients With Type 2 Diabetes.
Scott Kahan, Ken Fujioka. Diabetes Spectr 2017
10
10

Obesity: global epidemiology and pathogenesis.
Matthias Blüher. Nat Rev Endocrinol 2019
533
1

The T1D Exchange clinic registry.
Roy W Beck, William V Tamborlane, Richard M Bergenstal, Kellee M Miller, Stephanie N DuBose, Callyn A Hall. J Clin Endocrinol Metab 2012
299
1

Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass.
Deanna J M Isaman, Amy E Rothberg, William H Herman. Diabetes Care 2016
12
8


SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects.
Anastasios Tentolouris, Panayotis Vlachakis, Evangelia Tzeravini, Ioanna Eleftheriadou, Nikolaos Tentolouris. Int J Environ Res Public Health 2019
33
3


Double diabetes: A distinct high-risk group?
Noppadol Kietsiriroje, Sam Pearson, Matthew Campbell, Robert A S Ariëns, Ramzi A Ajjan. Diabetes Obes Metab 2019
9
11


Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.
Rakel F Johansen, Esben Søndergaard, Helle Linnebjerg, Parag Garhyan, Eric C Q Lam, Niels Porksen, Scott J Jacober, Søren Nielsen. Diabetes Obes Metab 2018
5
20

Epicardial adipose tissue thickness in type 1 diabetic patients.
Dilek Yazıcı, Beste Özben, Dilek Yavuz, Oğuzhan Deyneli, Hasan Aydın, Özlem Tarcin, Sema Akalın. Endocrine 2011
25
4

Is GLP-1 a hormone: Whether and When?
David D'Alessio. J Diabetes Investig 2016
36
2

An update on DPP-4 inhibitors in the management of type 2 diabetes.
Avivit Cahn, Simona Cernea, Itamar Raz. Expert Opin Emerg Drugs 2016
26
3

Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis.
Esther Donga, Olaf M Dekkers, Eleonora P M Corssmit, Johannes A Romijn. Eur J Endocrinol 2015
37
2


Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast-acting insulin aspart compared with insulin aspart.
Ananda Basu, Thomas R Pieber, Ann K Hansen, Stefanie Sach-Friedl, Lars Erichsen, Rita Basu, Hanne Haahr. Diabetes Obes Metab 2018
16
6



Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes.
S Mudaliar, R R Henry, T P Ciaraldi, D A Armstrong, P M Burke, J H Pettus, P Garhyan, S L Choi, M P Knadler, E C Q Lam,[...]. Diabetes Obes Metab 2016
12
8

Can clinical factors estimate insulin resistance in type 1 diabetes?
K V Williams, J R Erbey, D Becker, S Arslanian, T J Orchard. Diabetes 2000
273
1

Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes.
Jon C Olson, John R Erbey, Kimberly Y Z Forrest, Katherine Williams, Dorothy J Becker, Trevor J Orchard. Metabolism 2002
48
2

Adiposity and mortality in type 1 diabetes.
B Conway, R G Miller, T Costacou, L Fried, S Kelsey, R W Evans, T J Orchard. Int J Obes (Lond) 2009
46
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.